Heidelberg Pharma AG (ETR:HPHA)
2.550
-0.050 (-1.92%)
Jul 15, 2026, 5:35 PM CET
Heidelberg Pharma AG Market Cap
Heidelberg Pharma AG has a market cap or net worth of €119.3 million as of July 15, 2026. Its market cap has decreased by -43.86% in one year.
Market Cap
119.30M
Enterprise Value
110.12M
Revenue
3.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.55
Market Cap Chart
Since November 13, 2006, Heidelberg Pharma AG's market cap has decreased from 158.11M to 119.30M, a decrease of -24.54%. That is a compound annual growth rate of -1.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 119.30M | 2.83% |
| Dec 30, 2025 | 116.01M | 2.02% |
| Dec 30, 2024 | 113.72M | -34.75% |
| Dec 29, 2023 | 174.28M | -24.11% |
| Dec 30, 2022 | 229.66M | 41.34% |
| Dec 30, 2021 | 162.49M | -24.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 60.74B |
| Bayer Aktiengesellschaft | 49.04B |
| Siemens Healthineers AG | 38.58B |
| Fresenius SE & Co. KGaA | 23.48B |
| Stratec SE | 230.96M |
| MEDICLIN Aktiengesellschaft | 191.90M |
| LIMES Schlosskliniken AG | 160.89M |
| Viromed Medical AG | 156.19M |